SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001178913-24-001883
Filing Date
2024-05-29
Accepted
2024-05-29 16:08:53
Documents
16
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 PRE 14A zk2431513.htm   iXBRL PRE 14A 947222
6 GRAPHIC image0.jpg GRAPHIC 7645
  Complete submission text file 0001178913-24-001883.txt   1859406

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE entx-20231231.xsd EX-101.SCH 6178
3 XBRL DEFINITION FILE entx-20231231_def.xml EX-101.DEF 5506
4 XBRL LABEL FILE entx-20231231_lab.xml EX-101.LAB 15327
5 XBRL PRESENTATION FILE entx-20231231_pre.xml EX-101.PRE 5545
19 EXTRACTED XBRL INSTANCE DOCUMENT zk2431513_htm.xml XML 243027
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38556 | Film No.: 24998416
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)